Drugs / tripotassium dicitrate bismuthate
tripotassium dicitrate bismuthate
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03897244 | May 2019 → Feb 2025 | Helicobacter pylori infectious disease | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT07142798 | Sep 2024 → Dec 2025 overdue | Helicobacter pylori infectious disease | Kaohsiung Medical University | Enrolling by invitation | No outcome recorded |
| — | NCT02373280 | Aug 2014 → Apr 2027 expected | Helicobacter pylori infectious disease | Seoul National University Bundang Hospital | Recruiting | No outcome recorded |
| — | NCT02349685 | Jan 2010 → Jun 2014 | Helicobacter pylori infectious disease | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| Comparator or background therapy10 trials | ||||||
| Phase 3 | NCT03779074 Comparator | Sep 2018 → Dec 2021 | Helicobacter pylori infectious disease | Kaohsiung Veterans General Hospital. | Completed | No outcome recorded |
| Phase 4 | NCT02490839 Comparator | Jul 2015 → Nov 2018 | Helicobacter pylori infectious disease | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02483715 Comparator | Jul 2015 → Mar 2018 | Helicobacter pylori infectious disease | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01792700 Comparator | Jan 2003 → Dec 2010 | Helicobacter pylori infectious disease | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT07358130 Comparator | Oct 2025 → Nov 2027 expected | Helicobacter pylori infectious disease | Kaohsiung Medical University | Recruiting | No outcome recorded |
| — | NCT06349486 Comparator | Nov 2023 → Dec 2026 expected | — | Kaohsiung Medical University | Recruiting | No outcome recorded |
| — | NCT05850117 Comparator | Feb 2020 → Dec 2024 | — | Kaohsiung Medical University | Unknown | No outcome recorded |
| — | NCT03779087 Background | Jul 2018 → Jun 2020 | Helicobacter pylori infectious disease | Ping-I (William) Hsu, M.D. | Completed | No outcome recorded |
| — | NCT02359331 Comparator | Aug 2014 → Dec 2022 | Helicobacter pylori infectious disease | Seoul National University Bundang Hospital | Terminated | No outcome recorded |
| — | NCT01643785 Background | Jun 2012 → Jun 2013 | Helicobacter pylori infectious disease | Chuncheon Sacred Heart Hospital | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tripotassium dicitrate bismuthate | “Fourteen-day esomeprazole, tripotassium dicitrate bismuthate, metronidazole and tetracycline (EBMT) therapy or esomeprazole, moxifloxacin and amoxicillin (MEA) therapy was...” PMID 26452405 ↗ Oct 201513“rabeprazole 20 mg b.i.d. plus tripotassium dicitrate bismuthate 300 mg, tetracycline 500 mg and metronidazole 250 mg q.i.d. for 10 days” NCT03779074 ↗ “esomeprazole 40 mg bid., tripotassium dicitrate bismuthate 300mg qid, tetracycline 500 mg qid, levofloxacin 500 mg qd.” NCT03779087 ↗ “amoxicillin 750mg，Four times a day tripotassium dicitrate bismuthate 300mg，Four times a day for 14 days” NCT07142798 ↗ “Tri potassium dicitrate bismuthate, denol® 300 mg qid 7 days (D1-D7)” NCT02373280 ↗ “tripotassium dicitrate bismuthate 300mg QID” NCT01643785 ↗ |
| Known as | Colloidal Bismuth, Tripotassium dicitrate bismuthate, KCB | “Colloidal Bismuth, Tripotassium dicitrate bismuthate, KCB®” NCT03897244 ↗ |
| Known as | denol | “Tri potassium dicitrate bismuthate, denol® 300 mg qid 7 days (D1-D7)” NCT02373280 ↗ |